In the absence of a statistically significant difference in the primary endpoint between the two groups of a prospective randomized controlled trial against placebo, it is necessary to mention:
The risk of statistical error of the second kind (beta)
The lack of effect of the treatment
A lack of statistical power
The non-inferiority of the treatment evaluated
The risk of statistical error of the first type (alpha)